NCT07099768

Brief Summary

This study will be conducted to investigate the correlation between the flexibility of hip muscles; hip flexors (iliopsoas, rectus femoris), hip extensors (hamstring), hip internal rotators, hip external rotators, hip adductors and hip abductors with pain intensity and disability level among patients with chronic nonspecific low back pain

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

August 10, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2025

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

July 25, 2025

Last Update Submit

July 25, 2025

Conditions

Keywords

CorrelationFlexibility of Hip MusclesPainDisabilityNonspecific Low Back Pain

Outcome Measures

Primary Outcomes (3)

  • Flexibility of Hip Muscles

    Flexibility of the muscles of hip will be conducted on both the right and lift side and will be measure by universal Goniometer

    up to 1 day

  • Pain Intensity

    Visual analog scale is globally used as a measure of pain intensity. Visual analogue scale is the most frequent outcome tools in musculoskeletal pain assessment. An overall score between 0 and 10 points is given, with 'no pain' defined as 0 points and 'the most severe pain possible' defined as 10 points.

    up to 1 day

  • Disability

    Oswestry disability index is an internally consistent, unidimensional scale with overall excellent construct validity and ability to discriminate the severity of functional disability. The analysis suggests that the Oswestry disability index may better distinguish between the relative degrees of function at above-average disability levels. The Oswestry disability index is used to assess the extent of disability caused by low back pain, The Oswestry disability index consists of 10 questions on pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sexual activity, social life, and travel. Performance in each item is described in 6 stages, from 0 to 5 points, A higher score on the Oswestry disability index indicates more severe disability

    up to 1 day

Study Arms (1)

50 subjects aged between 20 and 45 years of both sexes with diagnosis of nonspecific low back pain

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

50 patients with chronic non specific low back pain from both gender will participate in this study

You may qualify if:

  • Chronic nonspecific low back pain for at least 3 months.
  • Age of the patient will range from 20 and 45 years.
  • Pain intensity of three or higher based on the visual analogue scale (VAS, 0-10 scale).
  • Body Mass Index from 18-25 kg/m2.

You may not qualify if:

  • spinal surgery, spinal or pelvic fracture.
  • ankylosing spondylitis or rheumatoid arthritis.
  • spondylolisthesis or spondylolysis, neurological disorders.
  • spinal inflammation or tumor. osteoporosis.
  • Continuous use of pain medications.
  • respiratory disease or heart disease.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Shimaa Mohamed, Master

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator: Shimaa Rabie Tony Mohamed

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 1, 2025

Study Start

August 10, 2025

Primary Completion

October 15, 2025

Study Completion

October 15, 2025

Last Updated

August 1, 2025

Record last verified: 2025-07